What is Seaport Res Ptn’s Estimate for HIMS FY2025 Earnings?

Hims & Hers Health, Inc. (NYSE:HIMS) – Seaport Res Ptn raised their FY2025 earnings per share (EPS) estimates for Hims & Hers Health in a research note issued on Monday, February 24th. Seaport Res Ptn analyst A. Kessler now expects that the company will earn $0.64 per share for the year, up from their previous estimate of $0.51. The consensus estimate for Hims & Hers Health’s current full-year earnings is $0.29 per share. Seaport Res Ptn also issued estimates for Hims & Hers Health’s FY2026 earnings at $1.10 EPS.

Other equities analysts have also issued reports about the company. Citigroup increased their price target on Hims & Hers Health from $25.00 to $27.00 and gave the company a “sell” rating in a research note on Tuesday. TD Cowen restated a “buy” rating and set a $28.00 price objective on shares of Hims & Hers Health in a research report on Wednesday, November 20th. Canaccord Genuity Group increased their target price on shares of Hims & Hers Health from $38.00 to $68.00 and gave the company a “buy” rating in a research note on Wednesday, February 19th. Bank of America raised their price objective on Hims & Hers Health from $18.00 to $21.00 and gave the stock an “underperform” rating in a research note on Thursday, February 20th. Finally, Leerink Partners increased their price target on Hims & Hers Health from $24.00 to $40.00 and gave the company a “market perform” rating in a research report on Tuesday. Two analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $34.47.

Hims & Hers Health Price Performance

NYSE HIMS opened at $41.87 on Thursday. Hims & Hers Health has a 12 month low of $11.20 and a 12 month high of $72.98. The firm has a market capitalization of $9.15 billion, a PE ratio of 95.15 and a beta of 1.35. The company’s 50 day simple moving average is $35.89 and its 200 day simple moving average is $26.36.

Hims & Hers Health (NYSE:HIMS) last released its earnings results on Monday, February 24th. The company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. The firm had revenue of $481.14 million for the quarter, compared to analysts’ expectations of $494.56 million. Hims & Hers Health had a net margin of 8.19% and a return on equity of 10.97%.

Insider Activity at Hims & Hers Health

In other Hims & Hers Health news, CEO Andrew Dudum sold 33,513 shares of the firm’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $33.38, for a total transaction of $1,118,663.94. Following the transaction, the chief executive officer now directly owns 33,502 shares in the company, valued at $1,118,296.76. This trade represents a 50.01 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Michael Chi sold 2,054 shares of the business’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $33.56, for a total value of $68,932.24. Following the completion of the sale, the insider now directly owns 184,947 shares of the company’s stock, valued at $6,206,821.32. This represents a 1.10 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 1,097,578 shares of company stock valued at $38,080,320. 17.71% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Hims & Hers Health

Hedge funds and other institutional investors have recently made changes to their positions in the business. B. Riley Wealth Advisors Inc. acquired a new stake in shares of Hims & Hers Health in the fourth quarter worth $200,000. Mackenzie Financial Corp grew its position in Hims & Hers Health by 44.6% in the 4th quarter. Mackenzie Financial Corp now owns 29,096 shares of the company’s stock worth $704,000 after purchasing an additional 8,977 shares during the last quarter. Public Employees Retirement System of Ohio bought a new position in shares of Hims & Hers Health during the 4th quarter worth about $99,000. Neo Ivy Capital Management increased its holdings in shares of Hims & Hers Health by 145.4% during the 4th quarter. Neo Ivy Capital Management now owns 166,734 shares of the company’s stock worth $4,031,000 after purchasing an additional 98,798 shares during the period. Finally, PharVision Advisers LLC acquired a new position in shares of Hims & Hers Health during the fourth quarter valued at about $234,000. 63.52% of the stock is owned by institutional investors and hedge funds.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.